Insulet Lawsuit Alleges EOFlow Stole Diabetes Tech

The complaint says that EOFlow developed its EOPatch insulin delivery system with the help of former Insulet employees and Insulet’s contract manufacturer. Medtronic announced plans to acquire EOFlow in May, and US FDA clearance is on the horizon.

PS1810_Trade Secrets_298803143_1200.jpg

South Korean device firm EOFlow Co., Ltd. worked with former Insulet Corporation employees and a contract manufacturer to copy Insulet’s Omnipod system, Insulet alleged in a lawsuit filed last week in Massachusetts federal court.

Omnipod became the first wearable and disposable insulin pump on the market when it won US Food and Drug Administration approval in 2005. The FDA cleared the most recent version...

More from Legal & IP

More from Policy & Regulation